4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
recent articles
4D Path and Daiichi Sankyo: Collaboration to leverage Q-Plasia OncoReader™ (QPOR™) on routine H&E slides to improve patient selection, accelerate clinical development, and deepen biological understanding of...
From the Tribun Health blog: Discover CaloPix Connect, Tribun Health’s open API to seamlessly integrate AI into pathology workflows, without disruption or added complexity. Artificial Intelligence is rapidly transforming pathology....
From the Proscia blog: How Proscia’s Concentriq platform transforms fragmented workflows into a scalable, AI-ready engine for precision medicine growth. Precision medicine is the frontier of modern oncology. Precision medicine companies...
bioAffinity Technologies: Invitation-only conference focuses on the evolving landscape of lung cancer risk and early detection when the disease is most treatable bioAffinity Technologies Chief Medical Officer Gordon Downie, MD, PhD, to...
BOSTON and COLUMBIA, Md., April 07, 2026 (GLOBE NEWSWIRE) -- PathAI, a leading provider of AI-powered pathology solutions, and MedStar Health, a leading health system headquartered in Columbia, Maryland, today announced a multi-year strategic...
Voicebrook and Corista: The Voicebrook-Corista integration enables hands-free slide navigation, AI interaction, and streamlined reporting for more efficient, connected pathology workflows. Roslyn Heights, NY, March 23, 2026...
